Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Cost-effectiveness analysis'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder / T. YUEN in Journal of Autism and Developmental Disorders, 48-9 (September 2018)
[article]
Titre : Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : T. YUEN, Auteur ; M. T. CARTER, Auteur ; P. SZATMARI, Auteur ; W. J. UNGAR, Auteur Article en page(s) : p.2968-2979 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Cost-effectiveness analysis Health services research Screening Index. décimale : PER Périodiques Résumé : The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes. En ligne : http://dx.doi.org/10.1007/s10803-018-3571-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367
in Journal of Autism and Developmental Disorders > 48-9 (September 2018) . - p.2968-2979[article] Cost-Effectiveness of Universal or High-Risk Screening Compared to Surveillance Monitoring in Autism Spectrum Disorder [Texte imprimé et/ou numérique] / T. YUEN, Auteur ; M. T. CARTER, Auteur ; P. SZATMARI, Auteur ; W. J. UNGAR, Auteur . - p.2968-2979.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 48-9 (September 2018) . - p.2968-2979
Mots-clés : Autism spectrum disorder Cost-effectiveness analysis Health services research Screening Index. décimale : PER Périodiques Résumé : The American Academy of Pediatrics recommends universal screening for autism spectrum disorder at 18 and 24 months. This study compared the cost-effectiveness of universal or high-risk screening to surveillance monitoring. Simulation models estimated the costs and outcomes from birth to age 6 years. The incremental cost per child diagnosed by 36 months was $41,651.6 for high-risk screening and $757,116.9 for universal screening from the societal perspective. Universal screening may not be a cost-effective approach to increase earlier treatment initiation, as most children initiated treatment after age 60 months. Eliminating wait times resulted in more children initiated treatment by 48 months, but at a high initial cost that may be offset by future cost-savings related to better outcomes. En ligne : http://dx.doi.org/10.1007/s10803-018-3571-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=367 Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects / J. Mick TILFORD in Journal of Autism and Developmental Disorders, 45-11 (November 2015)
[article]
Titre : Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects Type de document : Texte imprimé et/ou numérique Auteurs : J. Mick TILFORD, Auteur ; Nalin PAYAKACHAT, Auteur ; Karen A. KUHLTHAU, Auteur ; Jeffrey M. PYNE, Auteur ; Erica KOVACS, Auteur ; Jayne BELLANDO, Auteur ; D. Keith WILLIAMS, Auteur ; Werner B. F. BROUWER, Auteur ; Richard E. FRYE, Auteur Article en page(s) : p.3613-3623 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Child health Caregiver health Child sleep habits Quality adjusted life year Cost-effectiveness analysis Index. décimale : PER Périodiques Résumé : Sleep problems in children with autism spectrum disorders (ASD) are under-recognized and under-treated. Identifying treatment value accounting for health effects on family members (spillovers) could improve the perceived cost-effectiveness of interventions to improve child sleep habits. A prospective cohort study (N = 224) was conducted with registry and postal survey data completed by the primary caregiver. We calculated quality of life outcomes for the child and the primary caregiver associated with treatments to improve sleep in the child based on prior clinical trials. Predicted treatment effects for melatonin and behavioral interventions were similar in magnitude for the child and for the caregiver. Accounting for caregiver spillover effects associated with treatments for the child with ASD increases treatment benefits and improves cost-effectiveness profiles. En ligne : http://dx.doi.org/10.1007/s10803-015-2507-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=270
in Journal of Autism and Developmental Disorders > 45-11 (November 2015) . - p.3613-3623[article] Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects [Texte imprimé et/ou numérique] / J. Mick TILFORD, Auteur ; Nalin PAYAKACHAT, Auteur ; Karen A. KUHLTHAU, Auteur ; Jeffrey M. PYNE, Auteur ; Erica KOVACS, Auteur ; Jayne BELLANDO, Auteur ; D. Keith WILLIAMS, Auteur ; Werner B. F. BROUWER, Auteur ; Richard E. FRYE, Auteur . - p.3613-3623.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 45-11 (November 2015) . - p.3613-3623
Mots-clés : Autism spectrum disorder Child health Caregiver health Child sleep habits Quality adjusted life year Cost-effectiveness analysis Index. décimale : PER Périodiques Résumé : Sleep problems in children with autism spectrum disorders (ASD) are under-recognized and under-treated. Identifying treatment value accounting for health effects on family members (spillovers) could improve the perceived cost-effectiveness of interventions to improve child sleep habits. A prospective cohort study (N = 224) was conducted with registry and postal survey data completed by the primary caregiver. We calculated quality of life outcomes for the child and the primary caregiver associated with treatments to improve sleep in the child based on prior clinical trials. Predicted treatment effects for melatonin and behavioral interventions were similar in magnitude for the child and for the caregiver. Accounting for caregiver spillover effects associated with treatments for the child with ASD increases treatment benefits and improves cost-effectiveness profiles. En ligne : http://dx.doi.org/10.1007/s10803-015-2507-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=270